
|Articles|March 4, 2009
GSK and UCL team up
GlaxoSmithKline (GSK) and University College London's Institute of Ophthalmology have agreed a deal in which the Institute will investigate the potential of compounds provided by GSK's ophthalmic unit, Ophthiris.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
2
Study examines accommodation after iris-fixated phakic IOL implantation
3
AI-predicted retinal function shows promise in geographic atrophy
4
Mulling over options for mitigating severe vision loss from diabetes
5

























